# Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.

> PubMed lists PMID 15747448 in Prescrire international as Comparative Study, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15747448-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15747448-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15747448-teriparatide-v1.json
- Content SHA-256: `be7ac37e65555c692a1f1009ddc8e764d07504de76841740fdaee35b2c385cd8`

## Claims and source pins

### Headline

Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid. ([`pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3`](#source-pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3))

### Summary

PubMed lists PMID 15747448 in Prescrire international as Comparative Study, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3`](#source-pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3))

### Paragraph 1

PubMed lists PMID 15747448 in Prescrire international as Comparative Study, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3`](#source-pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3`](#source-pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3))

## Sources

<a id="source-pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3"></a>
- **Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid. · retained source version 1:2013-11-21:current:932218b3a6d3317d8cde8349f2abe234898b80e2beb616230a1b4c70c879c8ad** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15747448/) (`pubmed-observation-pmid-15747448-2013-11-21-932218b3a6d3`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-15747448-teriparatide-v1.json SHA-256: be7ac37e65555c692a1f1009ddc8e764d07504de76841740fdaee35b2c385cd8.